223 related articles for article (PubMed ID: 30854880)
21. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide.
Tatsuno I; Somogyvari-Vigh A; Mizuno K; Gottschall PE; Hidaka H; Arimura A
Endocrinology; 1991 Oct; 129(4):1797-804. PubMed ID: 1655384
[TBL] [Abstract][Full Text] [Related]
22. Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts.
Ruscheweyh R; Broessner G; Goßrau G; Heinze-Kuhn K; Jürgens TP; Kaltseis K; Kamm K; Peikert A; Raffaelli B; Rimmele F; Evers S
Cephalalgia; 2020 Dec; 40(14):1574-1584. PubMed ID: 32806953
[TBL] [Abstract][Full Text] [Related]
23. Baseline tear fluid CGRP is elevated in active cluster headache patients as long as they have not taken attack abortive medication.
Kamm K; Straube A; Ruscheweyh R
Cephalalgia; 2021 Jan; 41(1):69-77. PubMed ID: 32847402
[TBL] [Abstract][Full Text] [Related]
24. A prospective study of headache and neuropeptides in patients with pituitary adenomas.
Zhang Y; Pan Q; Jiang H; Yang G; Chen L; Qin G; Zhou J
Cephalalgia; 2019 Jul; 39(8):1049-1057. PubMed ID: 30897942
[TBL] [Abstract][Full Text] [Related]
25. Expression of Pituitary Adenylate Cyclase-activating Peptide, Calcitonin Gene-related Peptide and Headache Targets in the Trigeminal Ganglia of Rats and Humans.
Frederiksen SD; Warfvinge K; Ohlsson L; Edvinsson L
Neuroscience; 2018 Nov; 393():319-332. PubMed ID: 30336190
[TBL] [Abstract][Full Text] [Related]
26. Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients.
Fanciullacci M; Alessandri M; Sicuteri R; Marabini S
Brain; 1997 Feb; 120 ( Pt 2)():283-8. PubMed ID: 9117375
[TBL] [Abstract][Full Text] [Related]
27. CGRP pathway monoclonal antibodies for cluster headache.
Chan C; Goadsby PJ
Expert Opin Biol Ther; 2020 Aug; 20(8):947-953. PubMed ID: 32241175
[TBL] [Abstract][Full Text] [Related]
28. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache.
Ashina M; Bendtsen L; Jensen R; Schifter S; Jansen-Olesen I; Olesen J
Neurology; 2000 Nov; 55(9):1335-40. PubMed ID: 11087777
[TBL] [Abstract][Full Text] [Related]
29. From basic mechanisms to therapeutic perspectives in cluster headache.
Moreno-Ajona D; Hoffmann J
Curr Opin Neurol; 2022 Jun; 35(3):336-342. PubMed ID: 35674077
[TBL] [Abstract][Full Text] [Related]
30. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
31. Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case-Control and Case-Crossover Settings: A Systematic Review and Meta-Analysis.
Frederiksen SD; Bekker-Nielsen Dunbar M; Snoer AH; Deen M; Edvinsson L
Headache; 2020 Jun; 60(6):1132-1164. PubMed ID: 32293721
[TBL] [Abstract][Full Text] [Related]
32. CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine.
Cernuda-Morollón E; Martínez-Camblor P; Ramón C; Larrosa D; Serrano-Pertierra E; Pascual J
Headache; 2014 Jun; 54(6):987-95. PubMed ID: 24673487
[TBL] [Abstract][Full Text] [Related]
33. PACAP38 dose-response pilot study in migraine patients.
Vollesen AL; Guo S; Ashina M
Cephalalgia; 2017 Apr; 37(4):391-395. PubMed ID: 27084887
[TBL] [Abstract][Full Text] [Related]
34. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
35. Investigation of carbachol and PACAP38 in a human model of migraine.
Schytz HW
Dan Med Bull; 2010 Dec; 57(12):B4223. PubMed ID: 21122466
[TBL] [Abstract][Full Text] [Related]
36. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine.
Cernuda-Morollón E; Larrosa D; Ramón C; Vega J; Martínez-Camblor P; Pascual J
Neurology; 2013 Oct; 81(14):1191-6. PubMed ID: 23975872
[TBL] [Abstract][Full Text] [Related]
37. Plasma levels of vasoactive neuropeptides in pediatric patients with migraine during attack and attack-free periods.
Hanci F; Kilinc YB; Kilinc E; Turay S; Dilek M; Kabakus N
Cephalalgia; 2021 Feb; 41(2):166-175. PubMed ID: 32903061
[TBL] [Abstract][Full Text] [Related]
38. Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks.
Guo S; Petersen AS; Schytz HW; Barløse M; Caparso A; Fahrenkrug J; Jensen RH; Ashina M
Cephalalgia; 2018 Jul; 38(8):1418-1428. PubMed ID: 29082824
[TBL] [Abstract][Full Text] [Related]
39. Pituitary adenylate cyclase activating polypeptide immunoreactivity in capsaicin-sensitive nerve fibres supplying the rat urinary tract.
Fahrenkrug J; Hannibal J
Neuroscience; 1998 Apr; 83(4):1261-72. PubMed ID: 9502264
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP.
Schytz HW; Holst H; Arendt-Nielsen L; Olesen J; Ashina M
J Headache Pain; 2010 Aug; 11(4):309-16. PubMed ID: 20454993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
